Format

Send to

Choose Destination
Arthroscopy. 2003 Sep;19(7):740-5.

Electrothermal capsulorrhaphy in glenohumeral instability without Bankart tear.

Author information

1
Bone and Joint/Sports Medicine Institute, Naval Medical Center, Portsmouth, Virginia 23708, USA. jgenad@mar.med.navy.mil

Abstract

PURPOSE:

The purpose of this study is to review the clinical results of electrothermal capsulorrhaphy (ETC) performed on 23 patients for the treatment of glenohumeral instability at an minimum follow-up of 2 years.

TYPE OF STUDY:

Retrospective case series.

METHODS:

Twenty-six patients with symptomatic unidirectional or multidirectional glenohumeral instability without Bankart tear were treated with ETC using a radiofrequency probe. No labral repairs were performed. A standard postoperative rehabilitation protocol was followed. Patients were evaluated with respect to motion, direction of instability, need for repeat surgery, return to overhand sports, and symptoms of pain and instability using various scores.

RESULTS:

Twenty-three patients were available for follow-up evaluation at an average of 30 months. The overall average ASES and Rowe scores were 84.2 and 79.3, respectively. Recurrent instability requiring an open stabilization procedure occurred in 4 patients (17%), 2 with anterior and 2 with multidirectional instability. Seven of 14 overhead athletes (50%) reported inability to return to their previous level. According to Rowe scores, overall results were 11 excellent, 5 good, 4 fair, and 3 poor. No postoperative nerve complications occurred.

CONCLUSIONS:

The ETC procedure was safely performed to treat glenohumeral instability without Bankart lesions. The recurrence rate is similar to that for other arthroscopic procedures but higher than for open surgery. In the absence of Bankart tear, patients with multidirectional instability and overhand athletes may require something other than an isolated ETC procedure to address instability. Long-term results of ETC are needed to better define its surgical indications.

PMID:
12966382
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center